Rchr
J-GLOBAL ID：201801016607667154   Update date: Mar. 30, 2024

Fujihashi Kohtaro

フジハシコウタロウ | Fujihashi Kohtaro
Affiliation and department：
Chiba University Chiba University Hospital, Department of Human Mucosal Vaccinology

About Chiba University Chiba University Hospital, Department of Human Mucosal Vaccinology


Job title： Project Professor
Other affiliations (2)：
  • The University of Tokyo  The Institute of Medical Science, International Vaccine Design Center, Division of Mucosal Vaccine   Project Professor
  • The University of Alabama at Birmingham  School of Dentistry, Department of Pediatric Dentistry   Professor Emeritus
Research field  (1)： Immunology
Research keywords  (4)： Infectious Diseases ,  Aging ,  Mucosal Vaccine ,  Mucosal Immunology
Research theme for competitive and other funds  (18)：
  • 2020 - 2023 抗原非依存型ダブルシグナルシステムによる老化粘膜免疫の再生
  • 2020 - 2023 Rejuvenation of mucosal immunosenescence by the sublingual vaccine: The prevention and treatment for periodontal disease and arteriosclerosis
  • 2014 - 2016 Roles Of Adipose-Derived Mesenchymal Stem Cells For Mucosal Immunity In Aging
  • 2011 - 2013 Young Researcher Overseas Visits Program for Vitalizing Brain Circulation
  • 2006 - 2012 NALT-Based Adjuvants For Mucosal Immunity In Aging
Show all
Papers (218)：
  • Yoshikazu Yuki, Shiho Kurokawa, Kotomi Sugiura, Koji Kashima, Shinichi Maruyama, Tomoyuki Yamanoue, Ayaka Honma, Mio Mejima, Natsumi Takeyama, Masaharu Kuroda, et al. MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system. Frontiers in Plant Science. 2024. 15
  • Shingo Umemoto, Rika Nakahashi-Ouchida, Yoshikazu Yuki, Shiho Kurokawa, Tomonori Machita, Yohei Uchida, Hiromi Mori, Tomoyuki Yamanoue, Takehiko Shibata, Shin-Ichi Sawada, et al. Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents. NPJ vaccines. 2023. 8. 1. 106-106
  • Kayo Koyanagi, Kosuke Kataoka, Hideki Yoshimatsu, Kohtaro Fujihashi, Tatsuro Miyake. Human salivary protein-derived peptides specific-salivary SIgA antibodies enhanced by nasal double DNA adjuvant in mice play an essential role in preventing Porphyromonas gingivalis colonization: an in-vitro study. BMC Oral Health. 2023
  • Rika Nakahashi-Ouchida, Kohtaro Fujihashi, Yosuke Kurashima, Yoshikazu Yuki, Hiroshi Kiyono. Nasal vaccines: solutions for respiratory infectious diseases. Trends in molecular medicine. 2022. 29. 2. 124-140
  • Yoshikazu Yuki, Masanori Nojima, Koji Kashima, Kotomi Sugiura, Shinichi Maruyama, Shiho Kurokawa, Tomoyuki Yamanoue, Rika Nakahashi-Ouchida, Hiroyuki Nakajima, Takashi Hiraizumi, et al. Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults. Vaccine. 2022
ｍore...
MISC (174)：
ｍore...
Patents (1)：
  • Tolerizing Agents
Books (33)：
  • Mucosal vaccines : innovation for preventing infectious diseases
    Academic Press 2020 ISBN:9780128119242
  • Clinical immunology : principles and practice
    Elsevier 2019 ISBN:9780702068966
  • Handbook of Immunosenescence 2nd Edition : Basic Understanding and Clinical Implications
    Springer Science 2019
  • Principles of Mucosal Immunology. 2nd Edition
    Garland Science, Taylor & Francis Group, LLC 2019
  • Clinical Immunology 5th edition
    Elsevier Inc 2018
ｍore...
Professional career (1)：
  • Ph.D. (Osaka University)
Work history (1)：
  • 2022/04 - 現在 Chiba University Chiba University Hospital Department of Human Mucosal Vaccinology Project Professor
Committee career (1)：
  • 2015/01 - 2020/12 American Association of Immunologists Program Chair: Vaccines and Immunotherapy
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM